Sun Pharmaceutical Industries reported a net profit after tax of Rs 3,117.9 crore for Q2 FY26, marking a 2.6% year-on-year growth. The company’s revenue from operations also saw an 8.6% increase, reaching Rs 14,478 crore for the quarter ended September 2025.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets